CORCEPT THERAPEUTICS INC (CORT)
Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome
Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome
North Dallas Bank & Trust Co. Declares Regular Dividend
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
Other Report or Announcement
Collective Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 22, 2026
Verra Mobility Announces Organizational Changes to Accelerate Transformation and Enhance Customer Focus
Bristol Myers Squibb - Bristol Myers Squibb Announces Dividend
Bristol Myers Squibb Announces Dividend
Bristol Myers Squibb Announces Dividend
Rumble Announces Realignment into Two Core Business Units and Renames Newly Acquired Cloud And AI-Infrastructure Business “Quake AI”